These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29330024)

  • 21. Dengue virus NS4A cytoplasmic domain binding to liposomes is sensitive to membrane curvature.
    Hung YF; Schwarten M; Schünke S; Thiagarajan-Rosenkranz P; Hoffmann S; Sklan EH; Willbold D; Koenig BW
    Biochim Biophys Acta; 2015 May; 1848(5):1119-26. PubMed ID: 25644870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescent sterols: probe molecules of membrane structure and function.
    Schroeder F
    Prog Lipid Res; 1984; 23(2):97-113. PubMed ID: 6387716
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes.
    Mishra VK; Palgunachari MN
    Biochemistry; 1996 Aug; 35(34):11210-20. PubMed ID: 8780526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of Hsp90AA1 with phospholipids stabilizes membranes under stress conditions.
    Li P; Wang J; Zou Y; Sun Z; Zhang M; Geng Z; Xu W; Wang D
    Biochim Biophys Acta Biomembr; 2019 Feb; 1861(2):457-465. PubMed ID: 30517848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of a type 1 RIP and of its chimeric variant to phospholipid bilayers: evidence for a link between cytotoxicity and protein/membrane interactions.
    Pizzo E; Oliva R; Morra R; Bosso A; Ragucci S; Petraccone L; Del Vecchio P; Di Maro A
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):2106-2112. PubMed ID: 28797563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model membrane platforms to study protein-membrane interactions.
    Sezgin E; Schwille P
    Mol Membr Biol; 2012 Aug; 29(5):144-54. PubMed ID: 22831167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of a quercetin derivative - lensoside Aβ with liposomal membranes.
    Pawlikowska-Pawlega B; Kapral J; Gawron A; Stochmal A; Zuchowski J; Pecio L; Luchowski R; Grudzinski W; Gruszecki WI
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):292-299. PubMed ID: 29106971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How cellular membrane properties are affected by the actin cytoskeleton.
    Lemière J; Valentino F; Campillo C; Sykes C
    Biochimie; 2016 Nov; 130():33-40. PubMed ID: 27693515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
    Johnson JE; Rao NM; Hui SW; Cornell RB
    Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.
    Dathe M; Schümann M; Wieprecht T; Winkler A; Beyermann M; Krause E; Matsuzaki K; Murase O; Bienert M
    Biochemistry; 1996 Sep; 35(38):12612-22. PubMed ID: 8823199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visualizing association of lipidated signaling proteins in heterogeneous membranes--partitioning into subdomains, lipid sorting, interfacial adsorption, and protein association.
    Weise K; Triola G; Janosch S; Waldmann H; Winter R
    Biochim Biophys Acta; 2010 Jul; 1798(7):1409-17. PubMed ID: 20025847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
    Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
    Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolving the kinetics of lipid, protein and peptide diffusion in membranes.
    Sanderson JM
    Mol Membr Biol; 2012 Aug; 29(5):118-43. PubMed ID: 22582994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics characterization of c-Src binding to lipid membranes: Switching from labile to persistent binding.
    Le Roux AL; Busquets MA; Sagués F; Pons M
    Colloids Surf B Biointerfaces; 2016 Feb; 138():17-25. PubMed ID: 26638178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectroscopy of model-membrane liposome-protein systems: complementarity of linear dichroism, circular dichroism, fluorescence and SERS.
    Tukova A; Rodger A
    Emerg Top Life Sci; 2021 May; 5(1):61-75. PubMed ID: 33942863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleophosmin mutations in acute myeloid leukemia in children.
    Lawrence HJ
    Leukemia; 2007 Sep; 21(9):1849-50. PubMed ID: 17712359
    [No Abstract]   [Full Text] [Related]  

  • 38. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces.
    Clayton JC; Hughes E; Middleton DA
    Biochemistry; 2005 Dec; 44(51):17016-26. PubMed ID: 16363815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of a synthetic antimicrobial peptide with a model bilayer platform mimicking bacterial membranes.
    Niu L; Wohland T; Knoll W; Köper I
    Biointerphases; 2017 Aug; 12(4):04E404. PubMed ID: 28859483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pore-forming activity of BAD is regulated by specific phosphorylation and structural transitions of the C-terminal part.
    Polzien L; Baljuls A; Roth HM; Kuper J; Benz R; Schweimer K; Hekman M; Rapp UR
    Biochim Biophys Acta; 2011 Feb; 1810(2):162-9. PubMed ID: 21081150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.